98%
921
2 minutes
20
Aflatoxin B (AFB), a Group I carcinogen, poses severe health threats in food and environmental matrices, which requires ultra-sensitive monitoring tools. To address this, we engineered MS2 Virus-Like Particles (VLPs) via a novel triple-display strategy integrating: (i) surface-exposed nanobody N26 (fused to the A-protein) for specific recognition; (ii) high-density biotinylation (∼90 molecules/VLP, via Avi Tag insertion) for signal amplification; and (iii) C-terminal His-tags on coat protein dimers conferring organic solvent tolerance and simplified purification. The resulting Biotin-His&N26@MS2 VLP facilitates multivalent biotin-streptavidin interactions, dramatically amplifying detection signals. In indirect competitive ELISA, this platform achieved an ultra-low limit of detection (LoD) of 1 pg/mL for AFB - representing a >1000-fold improvement over monovalent biotin of nanobody N26 - with a broad linear range (5.3-34,400 ng/mL). Validation using spiked maize samples demonstrated high accuracy (recoveries: 84-128 %) and excellent correlation with LC-MS. Critically, the VLP retained full functionality in 20 % methanol, confirming its utility for complex matrices requiring organic solvent extraction. This work establishes a robust, organic solvent-tolerant VLP strategy enabling high-throughput surveillance of hazardous mycotoxins in agricultural and environmental settings.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.bios.2025.117916 | DOI Listing |
Biosens Bioelectron
December 2025
The Key Laboratory of Biological Targeting Diagnosis, Therapy and Rehabilitation of Guangdong Higher Education Institutes, The Fifth Affiliated Hospital, Guangzhou Medical University, Guangzhou, 511436, PR China; GMU-GIBH Joint School of Life Sciences, The Guangdong-Hong Kong-Macao Joint Laboratory
Aflatoxin B (AFB), a Group I carcinogen, poses severe health threats in food and environmental matrices, which requires ultra-sensitive monitoring tools. To address this, we engineered MS2 Virus-Like Particles (VLPs) via a novel triple-display strategy integrating: (i) surface-exposed nanobody N26 (fused to the A-protein) for specific recognition; (ii) high-density biotinylation (∼90 molecules/VLP, via Avi Tag insertion) for signal amplification; and (iii) C-terminal His-tags on coat protein dimers conferring organic solvent tolerance and simplified purification. The resulting Biotin-His&N26@MS2 VLP facilitates multivalent biotin-streptavidin interactions, dramatically amplifying detection signals.
View Article and Find Full Text PDF